07.02.2013 Views

Final Program in it's entirety - MyGirlsBlood

Final Program in it's entirety - MyGirlsBlood

Final Program in it's entirety - MyGirlsBlood

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Tuesday, July 13, 2010<br />

Congress Sessions cont’d<br />

n The Comb<strong>in</strong>ation of IL-4 and IL-10 Protects<br />

Aga<strong>in</strong>st Blood-Induced Cartilage Damage<br />

Van Meegeren M 1 , 2 , Jansen N 1 , 2 , Roosendaal G 2 ,<br />

Lafeber F 1<br />

1 Dept. of Rheumatology & Cl<strong>in</strong>ical Immunology<br />

and 2 Dept. Hematology and Van Creveld Cl<strong>in</strong>ic,<br />

UMC Utrecht, the Netherlands<br />

T1.4 – MEDICAL<br />

Free Papers III<br />

Room: Ceibo (1st floor)<br />

Chair: Annarita Tagiaferri, Italy, and Antonio Coppola,<br />

Italy<br />

n Ischemic Heart Disease: A New Challenge <strong>in</strong><br />

the Management of Hemophilia: Patients<br />

Between Bleed<strong>in</strong>g and Thrombotic Risk<br />

Coppola A1 , Santoro R2 , Rivolta G3 , Sch<strong>in</strong>co P4 ,<br />

Radossi P5 , Di Capua M6 1Regional Reference Centre For Coagulation<br />

Disoreders, Federico II University Hospital,<br />

Naples, 2Haemophilia Centre, Pugliese-Ciaccio<br />

Hospital, Catanzaro, 3Regional Reference Centre<br />

for Haemophilia, University Hospital, Parma,<br />

4Regional Reference Centre for Thrombotic and<br />

Haemorragic Disorders, Dep. of Haematology,<br />

University of Tur<strong>in</strong>, 5Transfusion and Haemophilia<br />

Centre, Hospital of Castelfranco Veneto, Italy<br />

n Cardiovascular Assessment <strong>in</strong> Adult<br />

Hemophilia Patients – A Pan-European Survey:<br />

The Advance Study Group<br />

Dolan G, on behalf of the ADVANCE Work<strong>in</strong>g<br />

Group<br />

Nott<strong>in</strong>gham University Hospitals, United<br />

K<strong>in</strong>gdom<br />

n Prophylaxis vs. On-Demand Therapy Through<br />

Economic Report (P.O.T.T.E.R.) Study: Results<br />

at 3-Year Follow-Up<br />

Tagliaferri A1 , Rivolta G1 , Feola G2 , Mancuso M3,<br />

Zanon E4 , Santoro C5 1Haemophilia Centre of Parma, Parma. Italy,<br />

2Haemophilia Centre of Vallo della Lucania, Vallo<br />

della Lucania, Italy, 3Haemophilia Centre of<br />

Milano, Milano, Italy, 4Haemophilia Centre of<br />

Padova. Padova, Italy, 5Haemophilia Centre of<br />

Roma, Roma, Italy<br />

n Prophylaxis Usage Among Different Age<br />

Groups with Hemophilia <strong>in</strong> Japan: Results from<br />

the ADVATE Post-Authorization Safety<br />

Surveillance (PASS) Studies<br />

Fukutake K1 , Taki M2 , Hanabusa H3 , Shima M4 ,<br />

Shirahata A5 and the Advate PASS study group6 1 2 Tokyo Medical University Hospital, Tokyo, St.<br />

30<br />

Marianna University School of Medic<strong>in</strong>e<br />

Yokohama City Seibu Hospital, Kanagawa,<br />

3 Ogikubo Hospital, Tokyo, 4 Nara Medical<br />

University, Nara, 5University of Environmental<br />

and Occupational Health Japan, Fukuoka, and<br />

6 Baxter BioScience Japan Medical Affairs Cl<strong>in</strong>ical<br />

Trial, Tokyo, Japan<br />

n LA-N8, a New Long-Act<strong>in</strong>g Recomb<strong>in</strong>ant FVIII,<br />

is Equipotent with Advate® <strong>in</strong> an Acute Tail<br />

Bleed<strong>in</strong>g Model <strong>in</strong> FVIII Knockout Mice<br />

Johansen PB, Tranholm M, Olsen EHN, Kjalke M,<br />

Jespersgaard C, Thim L, Andersen S, Bjørn SE,<br />

Stennicke HR<br />

Biopharmaceuticals Research Unit, Novo Nordisk<br />

A/S, Maaloev, Denmark<br />

n Development of Plasma Suppliers for the Indus -<br />

trial Production of Antihemophilic Factor VIII<br />

Zucchi A, Varela G, Massa C<br />

Laboratorio e Hemoderivados, Cordoba,<br />

Argent<strong>in</strong>a<br />

n Us<strong>in</strong>g New Technology Tools to Raise<br />

Awareness: World Hemophilia Day Case Study<br />

Ford S, Myles E<br />

World Federation of Hemophilia, Montreal, QC,<br />

Canada<br />

T1.5 – MULTIDISCIPLINARY<br />

MEET THE EXPERTS – Hepatitis C<br />

Room: Palermo<br />

Chair: Jorge Daruich, Argent<strong>in</strong>a<br />

n Panel: Kenneth Sherman, MD and Elizabeth<br />

Paradis, RN<br />

T1.6 – MULTIDISCIPLINARY≤<br />

Tw<strong>in</strong>n<strong>in</strong>g: Overcom<strong>in</strong>g the Barriers<br />

Rooms: Montserrat<br />

Chairs: Aris Hashim, Malaysia, and Nigel Key, U.S.A.<br />

n Concept of Tw<strong>in</strong>n<strong>in</strong>g<br />

Aris Hashim, Malaysia<br />

n Medical Tw<strong>in</strong>s<br />

Nigel Key, U.S.A.<br />

n Hot Tw<strong>in</strong>s<br />

Anthony Roberts, South Africa<br />

n South/South Tw<strong>in</strong>n<strong>in</strong>g<br />

Alok Srivastava, India<br />

12:15 – 14:15<br />

LUNCH BREAK AND INDUSTRY SYMPOSIA

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!